REAL-WORLD EVALUATION OF HEALTH CARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY (PDPN) TREATED WITH PREGABALIN OR GABAPENTIN

被引：0
|
作者：
Udall, M. [1 ]
Mardekian, J. [1 ]
Harnett, J. [1 ]
机构：
[1] Pfizer Inc, New York, NY USA
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
10.1016/j.jval.2011.02.360
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A64 / A64
页数：1
相关论文
共 50 条
  • [41] Healthcare Resource Utilization and Costs to Patients and Payers Among Real-World Patients with Follicular Lymphoma in the US Treated with Tazemetostat Compared to Other Standard-of-Care Therapies
    Dennen, Syvart
    Dillon, Allison
    Cockrum, Paul
    Kambhampati, Swetha
    BLOOD, 2024, 144 : 7626 - 7627
  • [42] Diabetic peripheral neuropathy: Evaluation of the association between neuropathic symptoms (NTSS-6-SA) and health care resource use and productive losses
    Currie, CJ
    Cawley, S
    Morgan, CL
    McEwan, P
    Price, P
    Peters, JR
    Covington, M
    VALUE IN HEALTH, 2005, 8 (06) : A167 - A167
  • [43] Evaluation of Real-World Healthcare Resource Utilization and Associated Costs in Children with Juvenile Idiopathic Arthritis: A Canadian Retrospective Cohort Study
    Luiza R. Grazziotin
    Gillian Currie
    Marinka Twilt
    Maarten J. Ijzerman
    Michelle M. A. Kip
    Hendrik Koffijberg
    Susanne M. Benseler
    Joost F. Swart
    Sebastiaan J. Vastert
    Nico M. Wulffraat
    Rae S. M. Yeung
    Nicole Johnson
    Nadia J. Luca
    Paivi M. Miettunen
    Heinrike Schmeling
    Deborah A. Marshall
    Rheumatology and Therapy, 2021, 8 : 1303 - 1322
  • [44] Real-World Treatment Patterns, Health Care Utilization, and Costs Among Relapsed/Refractory Multiple Myeloma (rrMM) Patients
    Shao, Changxia
    Monberg, Matthew
    Cao, Xiting
    Zhou, Wei
    Zhong, Yichen
    Marinello, Patricia
    BLOOD, 2016, 128 (22)
  • [45] Healthcare resource utilization and associated costs in patients with metastatic urothelial carcinoma: a real-world analysis using German claims data
    Niegisch, Guenter
    Grimm, Marc-Oliver
    Hardtstock, Fraence
    Krieger, Julia
    Starry, Alexandra
    Osowski, Ulrike
    Deiters, Barthold
    Maywald, Ulf
    Wilke, Thomas
    Kearney, Mairead
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 531 - 542
  • [46] Evaluation of Real-World Health Care Resource Utilization (HCRU) Among Patients with COPD Initiating Combination Tiotropium/Olodaterol Versus Triple Therapy
    Palli, S.
    Frazer, M.
    DuCharme, M.
    Buikema, A. R.
    Anderson, A. J.
    Elder, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [47] Real-world healthcare costs and resource utilization (HRU) among patients treated with erenumab in the United States: A retrospective claims database study
    Tepper, S. J.
    Schwedt, T. J.
    Vo, P.
    Joshi, P.
    Glassberg, M.
    Abdrabboh, A.
    Ferraris, M.
    Tiwari, S.
    Thompson, J.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 26 - 26
  • [48] Real-world healthcare costs and resource utilization (HRU) among patients treated with erenumab in the United States: A retrospective claims database study
    Tepper, S. J.
    Schwedt, T. J.
    Vo, P.
    Joshi, P.
    Glassberg, M.
    Abdrabboh, A.
    Ferraris, M.
    Tiwari, S.
    Thompson, J.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 17 - 18
  • [49] Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study)
    McArthur, Grant A.
    Mohr, Peter
    Ascierto, Paolo Antonio
    Arance, Ana
    Hernaez, Ana Banos
    Kaskel, Peter
    Weichenthal, Michael
    Shinde, Reshma
    Stevinson, Kendall
    ONCOLOGIST, 2017, 22 (08): : 951 - 962
  • [50] Persistence, Dose Titration, and Health Care Resource Utilization Among Crohn's Disease Patients Treated With Ustekinumab: A Real-World Analysis in the United States
    Obando, Camilo
    Ding, Zhijie
    Muser, Erik
    Vaidya, Neel
    Qiang, Wenqin
    Sun, Xiaoxi
    Wang, Huiqi
    Mallampati, Rajesh
    Xie, Lin
    ADVANCES IN THERAPY, 2020, 37 (05) : 2127 - 2143
12345